Testing renal function in practice
Authors:
Vladimíra Bednářová; Hana Šafránková
Authors place of work:
Klinika nefrologie VFN a 1. LF UK Praha
Published in the journal:
Vnitř Lék 2022; 68(E-1): 27-32
Category:
Dobrá rada
Summary
Chronic kidney disease patients often present late for dialysis due to minimal clinical symptoms, which are frequently undiscovered by both general practitioners and specialists. They have no information about renal replacement therapy, including preemptive kidney transplantation and do not have a permanent dialysis access. This fact increases the morbidity and mortality of those patients. Common preventive examinations such as blood pressure measurement, serum biochemistry, urinalysis, and glomerular filtration tests, might help with earlier diagnosis of these patients by others specialities and timely referral to nephrologist.
Keywords:
Glomerular filtration – albuminuria – chronic kidney disease
Zdroje
1. Jankowski J, Floege J, Fliser D et al. Cardiovascular Disease in Chronic Kidney Disease Circulation. 2021;143:1157-1172.
2. KDIGO 2012 Clinical Practice Guidiline for Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 2013;3:1-150.
3. Levey AS, Becker C, Inker LA. Et al. Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review JAMA 2015;313:837-846.
4. Mills KT,Xu Y, Zhang W et al. A systematic analysis of worldwide population- based data on the global of chronic kidney disease in 2010. Kidney Int 2015;88:950-7.
5. Thomas B, Matsuhita K Abata KH et al Global Cardiovascular and Renal Outcomes of reduced GFR. J Am Soc Nephrol 2017;28:2167-2179.
6. Koye DN, Magliano DJ, Reid ChM. Risk of Progression of Nonalbuminuric CKD to End‑Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study AmJ Kidney Dis 2018;72:653-661.
7. Chen TK, Knicely DH, Grams ME. Chronic Kidney Disease Diagnosis and Management: A Review JAMA 2019;322:1294.
8. Cherney DZI, Verma S: DAPA‑CKD: The Beginning of a New Era in Renal Protection J Am Coll Cardil Basic Trans Science 2021;6:74-77.
9.www.transplant.cz
10. Zimmerman AM, Peritoneal dialysis: inccreasing global utilization as an option for ranal replacement therapy. J Glob Health 2019;9: Published online 2019 Oct 7. doi: 10.7189/ jogh.09.020316.
11. Weinhandl ED, Foley RN, Gilbertson DT et al. Propensity‑Matchad Mortality Comparison of Incident Hemodialysis and Peritoneal dialysis JASN 2010;21:499-506.
12. Allon M. Vascular Access for hemodialysis Patients New Data Should Guide Decision Making CJASN 2019;14:954-961.
13. Ravani P, Quinn R, Oliver M et al. Assotiation between Hemodialysis Access Type and Mortality: The Role of Access Complications. CJASN 2017;12:955-964.
14. Rychlík: Statistická ročenka ČNS 2020 www.nefrol.cz.
15. Tu YR, Tsai TY, Lin et al. Association between initial dialytic modalities and the risks of mortality, infection death, and cardiovascular events: A nationwide population‑based cohort Sci Re2020;10:8066doi:10.1038/s41598-020-64986.
16. Zima T, Racek J, Ryšavá R et al. Doporučení k diagnostice chronického onemocnění ledvin Česká nefrologická společnost a Česká společnost klinické biochemie ČLS JEP Klin. Biochem. Metab., 2021;29: 94-103.
17. Vassalotti JA, Centor R, Turner BJ et al. Practical Approach to Detection and Management of Chronic Kidney Disease for the Primary Care Clinician AmJ Med 2016;129:153-162
18. Ping L, Rob RQ, Ngan NLl. Accounting for age in the definition of chronic kidney disease. JAMA Intern Med 2021;181:] 1359-1366.
19. Potok OA, Ix JH, Shlipak MG et al. The Difference Between Cystatin C- and Creatinine‑Based Estimated GFR and Associations With Frailty and Adverse Outcomes: A Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT) Am J Kidney, DiS. 2020 Dec;76(6):765-774.
20. Sumida K,Nadkarni G,Grams Me.Conversion of Urine Protein‑Creatinine Ratio or Urine Dipstick Protein to Urine Albumin‑Creatinine Ratio for Use in Chronic Kidney Disease Screening and Prognosis: An Individual Participant‑Based Meta‑analysis Annals of Internal Medicine 2020;6:173,426-465.
21. Glen P, Prashar A, Hawary A et al.Sterile pyuria: a practical mangement guide Br J Gen Pract. 2016 Mar; 66(644): e225-e227.
22. Judge C, Cifu AS, Faris S Management of Patients With Microhematuria JAMA. 2021;326(6):563-564.
23. KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease Kidney Int Supl. 2012; 283-287.
24. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD‑MBD) Kidney Int. Supl.2017;1-60.
Štítky
Diabetologie Endokrinologie Interní lékařstvíČlánek vyšel v časopise
Vnitřní lékařství
2022 Číslo E-1
- Není statin jako statin aneb praktický přehled rozdílů jednotlivých molekul
- Testování hladin NT-proBNP v časné diagnostice srdečního selhání – guidelines ESC
- Pregabalin je účinné léčivo s příznivým bezpečnostním profilem pro pacienty s neuropatickou bolestí
- Cinitaprid – v Česku nová účinná látka nejen pro léčbu dysmotilitní dyspepsie
- Syndrom Noonanové: etiologie, diagnostika a terapie
Nejčtenější v tomto čísle
- Možnosti cvičenia v liečbe ankylozujúcej spondylitídy
- Vyšetření renální funkce v praxi
- Zanechání kouření a riziko diabetes mellitus 2. typu
- Závažné zlyhávanie srdca a arytmia po protinádorovej liečbe podávanej v detstve